Cost-of-illness of patients with chronic hand eczema in routine care: Results from a multicentre study in Germany

British Journal of Dermatology

Volumn 165, Issue 4, 2011, Pages 845-851

  Augustin, M ^a   Kuessner, D ^b   Purwins, S ^a   Hieke, K ^c   Posthumus, J ^b   Diepgen, T L ^d  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b BASILEA PHARMACEUTICA INTERNATIONAL LTD   (Switzerland)

^c NEOS Health   (Switzerland)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC INFLAMMATION; COST OF ILLNESS; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; FEMALE; GERMANY; HAND ECZEMA; HEALTH SURVEY; HOSPITAL CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE; SYSTEMIC THERAPY; TOPICAL TREATMENT; ULTRAVIOLET IRRADIATION;

CHRONIC DISEASE; COST OF ILLNESS; COST-BENEFIT ANALYSIS; CROSS-SECTIONAL STUDIES; DERMATOLOGIC AGENTS; DRUG COSTS; ECZEMA; FEMALE; GERMANY; HAND DERMATOSES; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME; ULTRAVIOLET THERAPY;

EID: 80053496618     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10427.x     Document Type: Article

References (26)

1. Diepgen TL, Agner T, Aberer W, et al. Management of chronic hand eczema. Contact Dermatitis 2007; 57: 203-10. (Pubitemid 47397793)
2. Ruiz MA, Heras F, Alomar A, et al. Development and validation of a questionnaire on 'Satisfaction with dermatological treatment of hand eczema' (DermaSat). Health Qual Life Outcomes 2010; 127: 1-16.
3. Coenraads P, van Coevorden A, Diepgen T,. Hand eczema. In: Evidence-based Dermatology (, Williams H, Bigby M, Diepgen T, Herxheimer A, Naldi L, Rzany B, eds). London: BMJ Books, 2003; 132-43.
4. Meding B, Jarvholm B,. Hand eczema in Swedish adults-changes in prevalence between 1983 and 1996. J Invest Dermatol 2002; 118: 719-23. (Pubitemid 34309995)
5. Moberg C, Alderling M, Meding B,. Hand eczema and quality of life: a population-based study. Br J Dermatol 2009; 161: 397-403.
6. Fowler JF, Ghosh A, Sung J, et al. Impact of chronic hand dermatitis on quality of life, work productivity, activity impairment, and medical costs. J Am Acad Dermatol 2006; 54: 448-57. (Pubitemid 43243448)
7. Cvetkovski RS, Rothman KJ, Olsen J, et al. Relation between diagnoses on severity, sick leave and loss of job among patients with occupational hand eczema. Br J Dermatol 2005; 152: 93-8.
8. Blank PR, Blank AA, Szucs TD,. Cost-effectiveness of oral alitretinoin in patients with severe chronic hand eczema-a long-term analysis from a Swiss perspective. BMC Dermatol 2010; 10: 4.
9. Rodgers M, Griffin S, Paulden M, et al. Alitretinoin for severe chronic hand eczema: a NICE single technology appraisal. Pharmacoeconomics 2010; 28: 351-62.
10. Ruzicka T, Lynde CW, Jemec GB, et al. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial. Br J Dermatol 2008; 158: 808-17. (Pubitemid 351415754)
11. Coenraads PJ, Van Der Walle H, Thestrup-Pedersen K, et al. Construction and validation of a photographic guide for assessing severity of chronic hand dermatitis. Br J Dermatol 2005; 152: 296-301. (Pubitemid 40343601)
12. Hald M, Veien NK, Laurberg G, Johansen JD,. Severity of hand eczema assessed by patients and dermatologist using a photographic guide. Br J Dermatol 2007; 156: 77-80. (Pubitemid 44924148)
13. Diepgen TL, Elsner P, Schliemann S, et al. Guideline on the management of hand eczema ICD-10 Code: L20. L23. L24. L25. L30. J Dtsch Dermatol Ges 2009; 7 (Suppl. 3): S1-16.
14. Gray AM, Clarke PM, Wolstenholme JL, Wordsworth S,. Applied Methods of Cost-effectiveness Analysis in Health Care. Oxford: Oxford University Press, 2011.
15. Graf von der Schulenburg JM, Greiner W, Jost F, et al. German recommendations on health economic evaluation: third and updated version of the Hanover Consensus. Value Health 2008; 11: 539-44. (Pubitemid 352032814)
16. Finlay AY, Kahn GK,. Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-16. (Pubitemid 24194579)
17. Chren MM, Lasker RJ, Quinn LM, et al. Skindex, a Quality-of-Life measure for patients with skin diseases: reliability, validity and responsiveness. J Invest Dermatol 1996; 107: 707-13. (Pubitemid 26371086)
18. Augustin M, Wenninger K, Amon U, et al. German adaption of the 'Skindex-29' questionnaire on quality of life in dermatology: validation and clinical results. Dermatology 2004; 209: 14-20. (Pubitemid 39179100)
19. Augustin M, Lange S, Wenninger K, et al. Validation of a comprehensive Freiburg Life Quality Assessment (FLQA) core questionnaire and development of a threshold system. Eur J Dermatol 2004; 14: 107-13. (Pubitemid 38510027)
20. Blome C, Maares J, Diepgen T, et al. Measurement of patient-relevant benefits in the treatment of chronic hand eczema-a novel approach. Contact Dermatitis 2009; 61: 39-45.
21. Blome C, Augustin M, Siepmann D, et al. Measuring patient-relevant benefits in pruritus treatment: development and validation of a specific outcomes tool. Br J Dermatol 2009; 161: 1143-8.
22. Augustin M, Radtke MA, Zschocke I, et al. The patient benefit index: a novel approach in patient-defined outcomes measurement for skin diseases. Arch Dermatol Res 2009; 301: 561-71.
23. Augustin M, Amon U, Braathen L, et al. Assessment of quality of life in dermatology (guideline of the German Board of Medical Scientific Societies). J Dtsch Dermatol Ges 2004; 9: 802-6.
24. Ehlken B, Möhrenschlager M, Kugland B, et al. [Cost-of-illness study in patients suffering from atopic eczema in Germany]. Hautarzt 2005; 56: 1144-51: (In German). (Pubitemid 41719564)
25. Berger K, Ehlken B, Kugland B, Augustin M,. Cost-of-illness in patients with moderate and severe chronic psoriasis vulgaris in Germany. J Dtsch Dermatol Ges 2005; 7: 511 -1 8.
26. Schöffski O, Augustin M, Prinz J, et al. Costs and quality of life in patients with moderate to severe plaque-type psoriasis in Germany: a multi-center study. J Dtsch Dermatol Ges 2007; 5: 209-18. (Pubitemid 46361354)